The exceptions are liver cancer (HCC), where LGR5 expression is depressed relative to healthy tissue, and adrenal gland, oesophageal and pancreatic cancers that are not significantly different in LGR5 expression relative to healthy tissues. Here, LGR5 is linked to hepatocellular carcinoma.